{
    "pmid": "41431345",
    "title": "Seasonal Influenza Vaccine 2021/2022 Provides Limited Cross Reactivity Against Contemporary Swine Influenza A Virus Strains in Spain.",
    "abstract": "Swine influenza A viruses (SIVs) pose a zoonotic risk, with variants detected in humans in Europe. This study evaluated the efficacy of the 2021/2022 seasonal influenza vaccine against SIVs. Forty-six postvaccination human sera were tested via hemagglutination inhibition (HI) assay against Spanish SIV genotypes. Seroprotection rate (SPR, HI titer â‰¥ 40) was 76% (95% CI: 64-88) and 91% (95% CI: 83-99) for human vaccine strains H1 and H3, respectively. SPRs were 67% (95% CI: 53-81) for pandemic swine H1, 64% (95% CI: 50-78) for human seasonal-like H1, 17%-46% for Eurasian avian-like H1, 15% (95% CI: 5-25) for human seasonal-like H3 from the 1970s, and 83%-93% for human seasonal-like H3 from the 2000s SIVs.",
    "disease": "influenza",
    "clean_text": "seasonal influenza vaccine provides limited cross reactivity against contemporary swine influenza a virus strains in spain swine influenza a viruses sivs pose a zoonotic risk with variants detected in humans in europe this study evaluated the efficacy of the seasonal influenza vaccine against sivs forty six postvaccination human sera were tested via hemagglutination inhibition hi assay against spanish siv genotypes seroprotection rate spr hi titer was ci and ci for human vaccine strains h and h respectively sprs were ci for pandemic swine h ci for human seasonal like h for eurasian avian like h ci for human seasonal like h from the s and for human seasonal like h from the s sivs"
}